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An analytical procedure was developed for the determination of lead in different tissues from Wistar
Hanover rats, previously intoxicated with lead acetate during a toxicological study. About 25 mg of
dried sample (bone, liver, kidney, heart, lung and spleen) were mixed with 8.0 mL of 7.00 mol L1 nitric
acid and digested using microwave radiation in closed vessel. Except for the bone samples, the other
tissues could also be analyzed after alkaline solubilization with TMAH. All the digested or solubilized
samples were analyzed by graphite furnace atomic absorption spectrometry. Good accuracy and
precision were attained when analyzing reference standard materials (for bone, liver and kidney) and
also from addition to recovery experiments (for heart, lung and spleen tissues). The method was
applied to samples from nine animals and the results suggested that there is a proﬁle for lead
bioaccumulation in these animals, which seemed to adapt themselves to continuous lead exposure.
& 2012 Elsevier B.V. All rights reserved.1. Introduction
Due to historical [1] and toxicological aspects [2] lead is one of
the more important metallic species. For living beings, mainly
mammals, there is no evidence of essential function for this
element, which trends to accumulate in the bones and causes
many biochemical alterations [2–4].
Such alterations are considered irreversible and have the
following symptons for the human beings: anemia, muscular
fatigue, cognitive problems in children, hyperactivity, irritation,
gastrointestinal problems, diminished fertility (for males) and
reduced renal functions [2].
Consequently, it is current practice to treat individuals con-
taminated with lead in order to reduce their levels of contamina-
tion, as is done at the Clinical Hospital of the University of
Campinas (UNICAMP). In general, these patients are individuals
with bullets inside their bodies [5] as well as professionals that
have direct or indirect contact with lead such as shooting
instructors [6] and the employees of foundries [7]. On the other
hand, the amount of lead in the various affected organs has not
being considered in toxicological studies, or at least, has not been
reported.ll rights reserved.
ax: þ55 32 2102 3310.The effects caused by lead intoxication and the fact that this
element tends to accumulate in the bones are well known issues.
However, how the organs are involved in the bioacumulation
process and the extent of its bioaccumulation is not yet known.
In this context, the objective of this work is to present an
analytical protocol (and its application) speciﬁcally designed
for the determination of lead in bones and different organs
(liver, kidney, heart, lung and spleen) of Wistar Hanover
rats, which are generally the animals used in this kind of experi-
mental study.
Regarding the sample preparation possibilities, there are three
ordinary procedures to decompose the organic sample matrix of
those biological tissues in its inorganic constituents: dry ashing,
hot plate digestion or microwave digestion, which may be carried
out prior to the spectrometric analysis and commonly in acid
media. However, microwave digestion methods are preferred
because they are faster, more precise, avoid the loss of volatile
elements besides using small amounts of reagents [8].
On the other hand, alkaline solubilization of biological materials
was also shown to be an alternative for acid digestion in the cases of
some speciation analysis and when small sample amounts are
available. In this latter, the whole sample treatment can be done in
a single vessel and the use of small dilution volumes is then
facilitated. For this purpose TMAHs is one of the most used reagents,
mainly before analysis by GF AAS or techniques using an inductively
coupled plasma source (ICP OES or ICP-MS) [9].
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in this work, was carried out by Graphite Furnace Atomic
Absorption Spectrometry (GF AAS) after different sample pre-
parations (acid digestion in a microwave oven or alkaline solubi-
lization with ammonium tetramethylhydroxide—TMAH) in
biological tissues. The proposed method was shown to be appro-
priate for this kind of sample and all the selected tissues could be
analyzed due to the good GF AAS detectability (detection limits at
the mg kg1 level [10]), precision and small sample requirements.2. Experimental
2.1. Equipments and reagents
All chemical reagents were of analytical grade. Deionized water
(resistivity of 18.2 MO cm) was obtained with a Milli-Q System
(Millipore, Bedford, MA, USA). Nitric acid (Merck, Darmstadt) was
distilled before use. All sample containers, autosampler cups and
other materials were washed with neutral soap, soaked in 10% (v/v)
nitric acid for 24 h and rinsed with deionized water prior to use.
A 1000 mg mL1 lead solution (J. T. Baker, Center Valley, PA,
USA) was used to prepare the analytical standards in 0.2% (v/v)
HNO3, with concentrations between 1.0 and 50 mg L1. The
chemical modiﬁer was prepared from solid NH4H2PO4 (Ecibra,
S~ao Paulo), solid Mg(NO3)2 (Merck) and solid Pd(NO3)2 (Merck).
A microwave oven from Milestone (model ETHOS 1) was used
for acid sample digestion employing nitric acid, while for alkaline
sample solubilization 25% (v/v) tetramethylammonium hydro-
xide, TMAH (Fluka, St. Louis, USA) was used without heating.
All analytical measurements were made in a graphite furnace
atomic absorption spectrometer from Perkin-Elmer (Norwalk, CT,
USA, model A Analyst 600). This spectrometer is equipped with a
longitudinal Zeeman background corrector, auto sampler (model
AS-800), standard graphite tube with integrated Lvov platform and
transversal heating (THGA). The radiation source was a Pb electro-
deless discharge lamp—EDL (l¼283.3 nm; i¼360 mA) with slit
widths of 0.7 nm or 0.2 nm (for bone analysis). Pure argon was
employed as the inert gas at a ﬂow rate of 250 mLmin1. All the
measurements were made in integrated absorbance units.Table 1
Microwave digestion program employed for acid digestion of the
bones of Wistar Hanover rats.
Step Time (min) Temperature (1C)
1-Ramp 6 80
2-Hold time 2 80
3-Ramp 3 120
4-Hold time 4 120
5-Ramp 10 180
6-Hold time 15 180
7-Exhaust 40 0
Table 2
Instrumental parameters used to determine Pb2þ in the
Instrumental parameter Level for acid digested sa
Wavelength (nm) 283.3
Slit width (nm) 0.2 (bone) and 0.7 (other
Chemical modiﬁer 50 mg NH4H2PO4þ3 mg M
Pyrolysis temperature 850 1C
Atomization temperature 1550 1C
Replicates 2
Analytical curve media 0.2% (v/v) HNO3
Calibration type Linear with calculated inte2.2. Animals intoxication and sample treatment
The animals studied were male rats (Wistar Hanover) that
were raised under the same condition (environment and feed
availability) at the Experimental Medicine Department of the
Unicamp Medical School, following the Brazilian College for Animal
Experimentation authorization (Protocol 1600-1—Adaptative pro-
cesses in Wistar rats during subacute lead intoxication) and
rigorous ethical principles.
In order to intoxicate the animals, an aliquot of 0.50 mL of 1%
(m/m) lead acetate in distilled water was daily administrated to
each test animal, while for the control animals, which were not
intoxicated, lead acetate was substituted by daily aliquots of
0.50 mL of distilled water (placebo). In both cases the animals
were treated for different periods of time (eight, ﬁfteen, thirty and
sixty days) by the administration of the lead solution or the
placebo through intra-peritoneal injections. At the end of each
testing periods, the animals were sacriﬁced, and following this,
the organs (liver, kidney, heart, lung and spleen) and femur were
extracted and dried at 70 1C for 72 h. Afterwards, the bone tissue
was milled with a knife mill (IKA, A11 Basic) and then digested in
the microwave oven. The other tissues were solubilized in alka-
line media, due to the small amounts obtained of these dried
samples. Finally, the treated samples (organs and bone) were
diluted to 25 mL with deionized water and analyzed under the
selected conditions.
2.2.1. Acid digestion for bone and organs
This procedure was studied for all sample tissues while
developing the method but for the biomonitoring study this
digestion was only used for the bone samples. About 0.25 g of
each dried tissue were mixed with 8.0 mL of 7.00 mol L1 HNO3
acid in PTFE vessels and left in predigestion for 30 min. Then, the
vessels were closed and the samples were digested employing the
microwave oven operating under the conditions shown in Table 1.
2.2.2. Alkaline solubilization
The alkaline solubilization was very useful to deal with small
sample amounts, mainly for the spleen and heart, and all the
preparation procedure was made in the same ﬂask following a
sample/reagent proportion optimized for 25 mg of sample. In this
case, 1.00 mL of 25% (v/v) TMAH was added to the dried tissue
and the mixture was left overnight at room temperature. Then the
solubilized tissue was diluted to 25 mL with deionized water and
analyzed after manual agitation.
2.3. Instrument optimization
2.3.1. Conditions for the analysis of acid digests
In order to optimize the instrumental conditions, pyrolysis and
atomization curves were built for each tissue, previously fortiﬁed
with lead and after digesting according to Section 2.2.1. Compromisetissues of Wistar Hanover rats.
mples Level for solubilized samples (TMAH)
283.3
tissues) 0.7
g(NO3)2 5 mg Pdþ3 mg Mg(NO3)2
950 1C
1700 1C
2
1.0% (v/v) TMAH
rcept Linear with calculated intercept
Table 3
Heating program used to determine Pb2þ in digested rat tissues.
Step Temperature
(1C)
Ramp
(s)
Hold time
(s)
Ar ﬂow rate
(mL min)1
Drying 110; 130 7; 15 30; 30 250
Pyrolysis 850 10 20 250
Atomization 1550 0 3 0
Cleaning 2450 1 3 250
Table 4
Heating program used to determine Pb2þ in solubilized rat tissues.
Step Temperature
(1C)
Ramp
(s)
Hold time
(s)
Ar ﬂow rate
(mL min)1
Drying 110; 130 7; 15 30; 30 250
Pyrolysis 950 10 20 250
Atomization 1700 0 3 0
Cleaning 2450 1 3 250
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for the different digests and are shown in Tables 2 and 3. Accuracy
and precision tests were also done by analyzing certiﬁed reference
materials for bone, liver and kidney, while for heart, lung and spleen
tissues addition and recovery experiments were carried out.
2.3.2. Conditions for the analysis of alkaline samples
As for the acid digestion the main instrumental parameters
(pyrolysis and atomization temperatures) were evaluated also for
the solubilized tissues. The selected compromise conditions are
shown in Tables 2 and 4 and the accuracy was validated as the
same way done for the digested tissues.
2.4. Sample analysis for Pb biomonitoring
Under the procedures described above for digestion and
analysis of bone samples and for the alkaline solubilization of
the other tissues, all the samples were analyzed. These animals
belonged to ﬁve different testing groups: 1—control animals
(n¼3), 2—animals intoxicated for eight days (n¼2), 3—animals
intoxicated for ﬁfteen days (n¼3), 4—animals intoxicated for
thirty days (n¼2) and 5—animals intoxicated for sixty days
(n¼2). Although the objective was to analyze at least three
animals per group, due to difﬁculties regarding animal growth
and also some ethical aspects, in some groups only two animals
were used.3. Results
3.1. Sample treatment
3.1.1. Acid digestion as sample preparation
Based on reported procedures for bone, pig kidney and bovine
liver a unique sample treatment was evaluated for the different
tissues of interest.
For bone samples, the literature suggests masses between
0.1 and 1 g of dried sample, which can be mineralized with nitric
acid volumes varying from 5 to 10 mL [11–14]. These mixtures
were heated in a microwave oven, using closed vessels and
heating programs demanding 15 or 40 min [11–14].
For liver and kidney samples the procedures used are similar:
masses from 0.02 and 0.50 g of dried sample were mixed with
concentrated nitric acid [15–17] and hydrogen peroxide [18]. The
volumes of nitric acid varied from 0.4 to 7 mL, while those forperoxide varied from 0.2 to 1 mL [15,16,18]. Finally, these solu-
tions were submitted to microwave radiation with irradiation
times between 13 and 30 min [15,16].
Considering this information, the available sample masses and
the possibility of using diluted acid for sample preparation [19], a
digestion procedure was optimized for 0.25 g of dried sample and
8.0 mL of 0.70 mol L1 HNO3. Regarding the microwave heating
program, a slowly heating was used, due to the observation of
relatively high pressures (near to 20 bar), depending on the tissue,
in preliminary studies. Using the program shown in Table 1, the
lowest pressure was observed for bone (10 bar) and the highest
(20 bar) for the liver sample. In addition, the digests obtained
presented similar aspects for the different tissues: the solutions
were limpid, with no visible fat particles and then were consid-
ered adequate for direct use in the analyses.
3.1.2. Alkaline solubilization
Except for the bone and liver samples, only small amounts of
tissues were available, depending on the age of the animals,
especially in the controls and groups 2 and 3, mainly for heart and
spleen. In these cases, an alternative and more convenient
procedure was evaluated using alkaline solubilization.
Solubilization with TMAH was used for the different tissues
and 1.00 mL of the reagent was enough for complete samples
solubilization. The sample solutions presented a brown color and
a large amount of foam was observed during homogenization but
disappeared completely after a few minutes.
3.2. Instrumental parameters optimization
The following parameters were evaluated for the different
tissues, aiming to obtain compromise conditions for the different
samples: pyrolysis and atomization temperatures, use of chemical
modiﬁer and slit width.
In order to optimize the instrumental parameters the samples
used were from a no intoxicated animal. The tissues were then
fortiﬁed with Pb2þ in order to obtain sample solutions with
5.0 mg L1 Pb2þ .
3.2.1. Conditions for the analysis of acid digests
In preliminary tests and different from the other tissues, heart
and lung digests did not generate analytical signals, even when
low pyrolysis temperatures (such as 650 1C) were used. Trying to
understand this unexpected behavior, the sample digests were
analyzed by ICP OES (employing an Optima 3000DV spectro-
meter, Perkin-Elmer) and ion chromatography (Metrohm Mod-
ular IC, Metrohm) in order to determine the main elemental
constituents of the different samples and to verify possible
interferences.
The data obtained in the elemental analysis indicated the
presence of Al3þ , Ca2þ , Cu2þ , Cl , Fe2þ , Mg2þ , Mn2þ , Naþ , P
(probably in the phosphate form) and Zn2þ in all the tissues but
at different concentration levels. Among these elements, the
highest concentrations were obtained for Cl (from 805 to
3170 mg kg1), Mg2þ (from 492 to 605 mg kg1), Naþ (from
987 to 5171 mg kg1) and P (from 5908 to 56,153 mg kg1),
suggesting that some correlation between their concentrations
could explain the very low signals for the Pb2þ determinations in
the heart and lung samples.
Evaluating these data, it can be supposed that the Mg2þ and P
contents can act as a ‘‘natural’’ chemical modiﬁer for these samples,
affecting the atomization efﬁciency, especially by the amount of
chlorine, which favors the formation of volatile chlorides. To verify
this hypothesis the following ratio [amount of (Mg2þþP)]/[amount
Cl] was calculated for each sample and the values obtained were:
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bone (7415). These results showed that this ratio was really smaller
for the heart and lung samples than those for spleen, liver, kidney
and bone. Thus, a chemical modiﬁer was needed to avoid analyte
loss from heart to lung samples.
Considering that the mixture NH4H2PO4/Mg(NO3)2 is one of
the most used chemical modiﬁers for lead, mainly when high
pyrolysis temperatures are not necessary [20], this mixture was
used in the analysis of all the tissues.
Using 50 mg of NH4H2PO4 and 3 mg of Mg(NO3)2 as chemical
modiﬁer, pyrolysis and atomization curves were built for all the
samples studied (Fig. 1).
Fig. 1I shows that all the tissues presented a similar proﬁle
under the pyrolysis step, except for the heart and bone samples.
Then a compromise pyrolysis temperature of 850 1C was selected,
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Fig. 1. Pyrolysis (I) and atomization (II) curves for lead determination in different
animal rat tissues after acid digestion. (I) Temperature used for atomization: 1600
(1C) and (II) Temperature used for pyrolysis: 850 (1C).
Table 5
Recovery values obtained for Pb2þ in fortiﬁed samples (heart, spleen, lung) and refere
Tissue Reported value Fou
Bovine liver NIST-1577B 0.12970.004 mg kg1 0.11
Pig kidney BCR-186 306711 mg kg1 29
Hearta — 78
Bone NYS RM05-04 30.072.5 mg kg1 32
Lunga — 25
Spleena — 142
a Samples from an experimental rat, in which the ‘‘found value’’ correspond to the
b The added Pb2þ amounts (in mg kg1) varied for the different samples because the
solution was used for all the spikes.By ﬁxing the pyrolysis temperature at 850 1C the correspond-
ing atomization curves were obtained (Fig. 1II). Aiming to
evaluate the analytical signal and the peak proﬁle for this study
the signals were measured in peak height. In this case it was also
necessary to choose a compromise condition, which was 1550 1C.
Under the selected conditions (use of chemical modiﬁer,
pyrolysis and atomization temperatures) the accuracy of the
determinations was evaluated by analyzing samples of certiﬁed
reference materials and using addition and recovery experiments.
The results obtained are shown in Table 5.
Since the recovery values varied from 87 to 113%, the method
studied presented good accuracies for the different tissues. On the
other hand, it was necessary to use a smaller slit width for the
analysis of bone samples. This fact may be explained by a high
background interference, which is signiﬁcantly minimized by
reducing the slit width from 0.7 to 0.2 nm. Such an interference
was also observed by Zong et al. [14], who solved this problem by
using Ca(NO3)2 mixed with NH4H2PO4 (as chemical modiﬁer)
instead of Mg(NO3)2 with NH4H2PO4. Thus, this kind of ‘‘matrix
matching’’ was tried and the results were also satisfactory. Regard-
ing the other ﬁgures of merit (linearity and limits of detection and
quantiﬁcation) of the present study, they are presented in Table 6.
3.2.2. Conditions used to analyze the samples after alkaline
solubilization
Considering that the introduction of solubilized samples may
demand higher pyrolysis temperatures than those of digested
samples, a chemical modiﬁer must be used. The recommended
chemical modiﬁer for lead in such situations is the ‘‘universal
chemical modiﬁer’’ [20]. So, the pyrolysis and atomization tem-
peratures were optimized by using Pd/Mg(NO3)2 as chemical
modiﬁer. The curves obtained are shown in Fig. 2.
Fig. 2I shows that the tissues of liver, heart and spleen, in
TMAH media, are the most sensitive ones to the temperature
increase. Thus a compromise temperature for the pyrolysis step
was established as 950 1C, which corresponds to 100 1C above the
temperature used for the digested samples.nce samples (bovine liver, pig kidney and cheep bone) after acid digestion.
nd value Added valueb Recovery (%)
270.007 mg kg1 — 87
074 mg kg1 — 95
.577.1 mg kg1 150 mg kg1 100
.570.1 mg kg1 — 108
.076.9 mg kg1 161 mg kg1 113
.672.4 mg kg1 149 mg kg1 88
basal Pb2þ concentration.
sample masses weighed were not the same and a ﬁxed volume of a standard lead
Table 6
Linearity and limits of detection a (LOD) and quantiﬁcation b (LOQ) obtained for
the analysis of acid digests.
Slit
width
(nm)
Evaluated
range
(mg L1)
Linear
correlation
coeﬁcient
Instrumental
LOD and LOQ
(mg L1)
Experimental
LOD and LOQ
(mg kg1)
0.7c 1–100 R2¼0.9991 0.16 and 0.51 16 and 51
0.2d 1–100 R2¼0.9968 0.48 and 1.44 48 and 144
a The LOD was calculated as three times the standard deviation (n¼10) [10]
for a blank solution (HNO3 0.2% v/v).
b The LOQ was calculated as nine times the standard deviation (n¼10) [10] for
the same blank solution (HNO3 0.2% v/v) used for the LOD estimative.
c Slit width used to analyze heart, liver, kidney, lung and spleen samples.
d Slit width used to analyze bone samples.
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tion temperature was evaluated for liver and heart tissues (in
which the lead signal was shown to be less stable, during
increasing temperature) and lung tissue (that presented the best
thermal stability for lead).
According to Fig. 2II, small changes on the absorbance signals
were observed, at about 13% among the evaluated atomization
temperatures. On the other hand, considering that an atomization
temperature of 1700 1C led to higher absorbance values and750 800 850 900 950 1000 1050
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Fig. 2. Pyrolysis (I) and atomization (II) curves obtained for the sample tissues
after alkaline solubilization with TMAH. (I) Temperature used for atomization:
1900 (1C) and (II) Temperature used for pyrolysis: 950 (1C).
Table 7
Lead concentrations obtained for the analysis of fortiﬁed (heart, lung and spleen) and
Sample Reported value Found va
Bovine liver NIST-1577B 0.12970.004 mg kg1 0.12570
Pig kidney BCR-186 306711 mg kg1 32774
Hearta — 56.974
Lunga — 48.970
Spleena — 58.572
a Samples from an experimental rat, in which the ‘‘found value’’ correspond to the
b The added Pb2þ amounts (in mg kg1) varied for the different samples because th
solution was used for all the spikes.more precise signals, this value was selected for the atomization
temperature.
Thus, employing the instrumental conditions optimized for the
samples solubilized with TMAH (Tables 2 and 4), the method
accuracy was evaluated by analyzing certiﬁed reference materials
and also by addition and recovery experiments, as illustrated in
Table 7. Good recovery values for lead can be observed, from 91 to
107%. These results show that the alkaline solubilization and the
instrumental conditions used present good accuracies for the
analysis of these kinds of tissues.
Under the optimized conditions the parameters linear range,
limit of detection (LOD) and limit of quantiﬁcation (LOQ) were
evaluated and are presented in Table 8.
The method LOD and method LOQ values are related to sample
dilution and are higher than those obtained for the acid digestion.
However, this difference is small and the solubilization of rat organs
with TMAH can be used without signiﬁcant loss of detectability.
In relation to the sample and standard media, a comparison
between analytical curves prepared in nitric acid (0.2% HNO3) and
TMAH showed that there are signiﬁcant differences at the 95%
conﬁdence level. Thus the analytical curves must be prepared
using the same alkalinity (with TMAH) as the samples.3.3. Sample analysis for Pb biomonitoring
The optimized procedures for bone analysis (after acid diges-
tion) and organs (employing alkaline solubilization) were applied
for a group of 12 animals, evaluated as 72 different tissues,
prepared and analyzed in duplicate, whenever possible (tissue
dry weight higher than 50 mg).
Except for the control group, in which the analyte was not
detected, all the other samples were diluted, as the corresponding
sample solutions presented more than 100 mg L1 Pb2þ (upper limit
of the analytical curve). In this context it is very important to
emphasize that different dilutions were used for the different tissue
samples and even for animals of the same group. This fact showed
that lead is signiﬁcantly absorbed by some tissues although the
concentration values showed a relatively high deviation between the
replicates that corresponded to different animals.
The results are shown in Table 9, where the lead concentrations
are also expressed in ‘‘accumulated percentage’’, that is, the total leadreference samples (bovine liver and pig kidney) after alkaline solubilization.
lue Added value ( mg kg1)b Recovery (%)
.007 mg kg1 — 97
mg kg1 — 107
.3 mg kg1 280 100
.6 mg kg1 241 93
.4 mg kg1 283 91
basal Pb2þ concentration.
e sample masses weighed was not the same and a ﬁxed volume of a standard lead
Table 8
Figures of merit for the analysis of rat tissues after solubilization with TMAH.
Linear range
(evaluated)
Correlation
coefﬁcient
Instrumental LODn
and LOQn
Method LOD
and LOQ
1–100 mg L1 R2¼0.9961 0.24 nd 0.71 mg L1 24–71 mg kg1
n The LOD was calculated as three times the standard deviation (n¼10) [10]
for a blank solution (TMAH 4% v/v) and the LOQ was calculated as nine times the
standard deviation (n¼10) [10] for the same blank solution.
Table 9
Lead concentration determined by GF AAS in intoxicated animals.
Group 1: Eight days (n¼2) 2: Fifteen days (n¼3) 3: Thirdy days (n¼2) 4: Sixty days (n¼2)
Tissue Pb content
(mg g1)
Pb accumulated
porcentage
Pb content
(mg g1)
Pb accumulated
porcentage
Pb content
(mg g1)
Pb accumulated
porcentage
Pb content
(mg g1)
Pb accumulated
porcentage
Heart 0.001070.0005 0.1270.03 0.004–0.30a 0.11–0.58 a 0.17–0.37 a 1473 0.047–0.20a 8–16 a
Lung 0.003–0.013 a 0.26–1.15 a 0.014–0.556 a 0.46–1.84 a 0.17–0.85 a 14–36 a 0.08–0.37 a 13–28 a
Liver 0.05770.020 571 0.04670.004 571 0.1370.02 872 0.03470.002 2–6 a
Kidney 0.08670.003 871 0.1170.02 1573 0.16–0.42 a 7–34 a 0.1270.01 9–21 a
Bone 0.09970.003 1071 0.06470.002 771 0.08770.016 4–7 a 0.1670.01 11–24 a
Spleen 0.7670.12 7671 0.5970.08 7177 0.32–0.79 a 2875 0.24–0.70 a 3174
Total
accumulated
lead
1.01mg g1 0.82mg g1 1.84mg g1 1.13mg g1
a This concentration range corresponds to the lowest and highest lead concentrations determined for the replicates (animals) since the values varied signiﬁcantly in
the same group.
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normalize the data considering that the animals had absorbed
different lead amounts, due to the different times of intoxication,
but could have the analyte proportionally distributed among their
tissues.
The data from Table 9 showed that the lead has accumulated
mainly in the liver, kidney, bone and spleen tissues up to a
period of ﬁfteen intoxication days. Although the higher amounts
were found for the spleen in this period, a decreasing trend was
observed for this tissue and also for the bone. Concomitantly, the
contents found for kidney showed an increasing trend (from 8 to
15%), comparing the groups from eight and ﬁfteen days.
This behavior suggests that an adaptation process might occur, as
the animals would be detoxifying themselves. Such hypothesis is
reasonable since the kidneys are responsible for the blood impurities
elimination [21] and also considering that the total lead accumu-
lated in the different tissues during ﬁfteen days (0.82 mg g1) is 19%
lower than the value accumulated during eight days (1.01 mg g1).
In addition, the increase in the lead contents for the lung and heart
tissues along all the experiments indicated that the lead is being
eliminated. Since this phenomenon is already known for bones [1], it
can be considered that the lead accumulated in the spleen and also
in the bones participates in a chemical equilibrium between ‘‘lead
from tissues’’ and ‘‘lead from blood’’. At ﬁfteen days this equilibrium
is disturbed in the direction of increasing the lead amounts in the
blood, favoring its elimination through urine.
This consideration could also explain the results obtained for
the animals intoxicated for thirty days. In these animals the lead
amounts found in the spleen and bone tissues continued to
diminish while the lead amounts for the other tissues (kidney,
liver, lung and heart) increased.
Thus, the results showed that the animals studied were capable
of adapting themselves to a continuous lead exposure up to a period
of sixty days of intoxication, when the experiment ended.
In addition, these data are in agreement with ones obtained in
clinical studies for other animals submitted to the same intoxica-
tion treatment. In this case, the animals presented anemia and
renal dysfunctions up to thirty days, after which the symptoms
decreased and the animals started showing general health
improvement between the thirty and sixty days.4. Conclusions
Two analytical methods, based on the GF AAS technique, were
evaluated and applied for lead determination in Wistar Hanover
rats. One of the methods used an acid digestion, appropriate forbone analysis, and the other used an alkaline solubilization, which
is feasible for the organ tissue samples and was more convenient
due to the small amounts of each sample. For this latter proce-
dure, TMAH was used for sample solubilization without heating
or agitation. On the other hand, the analytical methodology
showed that the conditions used to analyze the bone samples
could also be employed for the other tissue samples.
Application of these methods allowed to analyzing the differ-
ent tissues (bone, liver, kidney, spleen, lung and heart) in all the
animals studied experimentally and the results gave new infor-
mation on lead accumulation in rats. In fact, there was signiﬁcant
lead accumulation in the bones but other tissues, such as spleen,
liver, kidney, lung and heart, were also involved in this process.
Additionally, the animals seem to adapt themselves to the analyte
exposure since the lead accumulation did not increase propor-
tionally throughout the intoxication period. In this context the
role of these organs was shown to be very important and
complementary studies should be done aiming to understand
the processes that could be stimulated to favor metal elimination
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